ClinicalTrials.Veeva

Menu

Robotic Medial Congruent Vs. Conventional Medial Pivot TKA

G

George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures (UMFST)

Status

Enrolling

Conditions

Knee Osteoarthristis

Treatments

Procedure: Robotic assisted total knee arthroplasty
Procedure: Conventional total knee arthroplasty (cTKA)

Study type

Interventional

Funder types

Other

Identifiers

NCT06858358
rosa_MP_MC_3002025

Details and patient eligibility

About

This multicenter, prospective cohort study will evaluate whether Robotic-Assisted total knee arthroplasty (RATKA) with a Medial Congruent implant is a successful method to improve implant alignment, insert thickness accuracy, and patient satisfaction, compared to a conventional TKA (cTKA) Medial Pivot technique. It aims to assess and compare clinical and functional outcomes in patients with severe knee osteoarthritis at 3, 6, and 12 months.

Full description

This prospective, non-randomized, multicenter trial evaluates robotic-assisted (ROSA® Robotic Platform with Zimmer Biomet Persona® Medial Congruent) versus conventional (MicroPort Evolution® Medial-Pivot) total knee arthroplasty (TKA) in approximately 300 adults with severe osteoarthritis. By comparing robotic precision with a well-established Medial-Pivot design, this investigation aims to clarify whether robotic-assisted TKA confers superior implant positioning, reduced alignment outliers, and enhanced patient-reported outcomes (PROMS). The primary outcome measures include insert thickness, alignment accuracy (outliers defined as >2° from the mechanical axis on full-leg radiographs), and patient satisfaction at 6 and 12 months. Two surgeons will perform both techniques, and one surgeon will perform only the conventional procedure. The 18-month study is conducted under local Institutional Review Board approvals (Medlife, Medicover, SCJU Cluj Napoca, Monza Bucuresti) and complies with GDPR. Results are intended for publication in a high-impact orthopedic journal. No external funding is provided.

Enrollment

300 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients with severe osteoarthritis (greater than III Ahlback)

Exclusion criteria

Patients who refuse participation in the study Low-grade osteoarthritis

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

300 participants in 2 patient groups

ROSA Robotic-assisted TKA with Zimmer Biomet Persona Medial Congruent implant
Experimental group
Treatment:
Procedure: Robotic assisted total knee arthroplasty
Conventional TKA with Microport Evolution Medial-Pivot
Experimental group
Treatment:
Procedure: Conventional total knee arthroplasty (cTKA)

Trial contacts and locations

2

Loading...

Central trial contact

Marian A Melinte; Razvan M Melinte, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems